A detailed history of Impact Capital Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Impact Capital Partners LLC holds 26,411 shares of ABBV stock, worth $6.18 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares
26,411
Previous 24,471 7.93%
Holding current value
$6.18 Million
Previous $4.54 Billion 34.63%
% of portfolio
1.84%
Previous 1.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$184.85 - $231.54 $358,609 - $449,187
1,940 Added 7.93%
26,411 $6.12 Billion
Q2 2025

Jul 18, 2025

BUY
$170.16 - $206.27 $56,833 - $68,894
334 Added 1.38%
24,471 $4.54 Billion
Q1 2025

Apr 11, 2025

BUY
$169.2 - $216.66 $377,485 - $483,368
2,231 Added 10.18%
24,137 $5.06 Billion
Q4 2024

Feb 10, 2025

BUY
$164.99 - $203.87 $3.61 Million - $4.47 Million
21,906 New
21,906 $3.89 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Impact Capital Partners LLC Portfolio

Follow Impact Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impact Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Impact Capital Partners LLC with notifications on news.